Optic Nerve Injuries: Clinical Trials

3 trials for Optic Nerve Injuries, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 unknown. 3 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 33Completed 2, Unknown 1
Phase 21Unknown 1

Follow Optic Nerve Injuries: new trials by email Literature Review of Optic Nerve Injuries trials Research Report on Optic Nerve Injuries

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Intravenous Methylprednisolone and Intravenous Erythropoietin in Toxic Optic Neuropathies: Randomized Clinical Trial.
Recombinant human erythropoietin 4,000 UI and 2,000 UI, Methylprednisolone succinate 500 mg - Toxic Optic Neuropathy, Treatment
Phase 2 / Phase 3UnknownAsociación para Evitar la Ceguera en México182022-04-052023-02-28
Therapy of Toxic Optic Neuropathy Via Combination of Stem Cells With Electromagnetic Stimulation
Wharton jelly derived mesenchymal stem cell, Repetitive electromagnetic stimulation - Methanol Poisoning, Toxic Optic Neuropathy
Phase 3CompletedAnkara Universitesi Teknokent182019-04-012021-05-10
Traumatic Optic Neuropathy Treatment Trial 2
Recombinant human erythropoietin - Traumatic Optic Neuropathy
Phase 3CompletedIran University of Medical Sciences932018-01-062024-03-08

Narrower conditions

Toxic Optic Neuropathy (2)

Broader conditions

Cranial Nerve Diseases (3)  ·  Cranial Nerve Injuries (3)  ·  Craniocerebral Trauma (3)  ·  Eye Diseases (3)  ·  Nervous System Diseases (3)  ·  Optic Nerve Diseases (3)  ·  Trauma, Nervous System (3)  ·  Wounds and Injuries (3)  ·  Chemically-Induced Disorders (2)  ·  Drug-Related Side Effects and Adverse Reactions (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Radiation Injuries (2)

Interventions

Control Groups (1)  ·  Epoetin Alfa (1)  ·  Methylprednisolone Hemisuccinate (1)

Sponsors

Ankara Universitesi Teknokent (1)  ·  Asociación para Evitar la Ceguera en México (1)  ·  Iran University of Medical Sciences (1)

Countries

Iran (1)  ·  Mexico (1)  ·  Turkey (Türkiye) (1)

Top investigators

Mohsen B Kashkouli, MD (1)  ·  Octavio Turcio-Aceves, MD (1)

Results publications

PMID 34579767, PMID 39461733